+Compare
BRKR
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
9.01B

BRKR Bruker Corp Forecast, Technical & Fundamental Analysis

a manufacturer of analytical and medical instruments

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for BRKR with price predictions
07:00 PM EST Nov 30, 2023

BRKR in upward trend: price rose above 50-day moving average on November 14, 2023

BRKR moved above its 50-day moving average on November 14, 2023 date and that indicates a change from a downward trend to an upward trend. In of 36 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 10, 2023. You may want to consider a long position or call options on BRKR as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BRKR just turned positive on November 07, 2023. Looking at past instances where BRKR's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for BRKR crossed bullishly above the 50-day moving average on November 24, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BRKR advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 288 cases where BRKR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRKR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BRKR broke above its upper Bollinger Band on November 21, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BRKR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.453) is normal, around the industry mean (25.181). P/E Ratio (30.134) is within average values for comparable stocks, (79.550). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.249). Dividend Yield (0.003) settles around the average of (0.019) among similar stocks. P/S Ratio (3.409) is also within normal values, averaging (44.232).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.4B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 4%. For the same Industry, the average monthly price growth was 13%, and the average quarterly price growth was 704%. LNDZF experienced the highest price growth at 347%, while SDCCQ experienced the biggest fall at -31%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 107%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was 13%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 60
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: 17 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

BRKR is expected to report earnings to fall 12.69% to 64 cents per share on February 08

Bruker Corp BRKR Stock Earnings Reports
Q4'23
Est.
$0.65
Q3'23
Beat
by $0.11
Q2'23
Beat
by $0.01
Q1'23
Beat
by $0.09
Q4'22
Beat
by $0.01
The last earnings report on November 02 showed earnings per share of 74 cents, beating the estimate of 62 cents. With 669.44K shares outstanding, the current market capitalization sits at 9.01B.
A.I.Advisor
published Dividends

BRKR is expected to pay dividends on December 15, 2023

Bruker Corp BRKR Stock Dividends
A dividend of $0.05 per share will be paid with a record date of December 15, 2023, and an ex-dividend date of November 30, 2023. The last dividend of $0.05 was paid on September 15. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of analytical and medical instruments

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
40 Manning Road
Phone
+1 978 663-3660
Employees
8525
Web
https://www.bruker.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NCLH16.421.15
+7.53%
Norwegian Cruise Line Holdings Ltd
FIO.X0.0240530.000259
+1.09%
FIO Protocol cryptocurrency
FET.X0.558847-0.002424
-0.43%
Fetch.ai cryptocurrency
API3.X1.538191-0.031274
-1.99%
API3 cryptocurrency
TLM.X0.015278-0.000751
-4.69%
Alien Worlds cryptocurrency

BRKR and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRKR has been closely correlated with A. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if BRKR jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRKR
1D Price
Change %
BRKR100%
+1.49%
A - BRKR
67%
Closely correlated
+0.77%
WAT - BRKR
66%
Loosely correlated
+2.94%
MTD - BRKR
62%
Loosely correlated
+1.15%
TMO - BRKR
57%
Loosely correlated
+0.07%
DHR - BRKR
53%
Loosely correlated
+0.08%
More

Groups containing BRKR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRKR
1D Price
Change %
BRKR100%
+1.49%
thermal
(undefined stocks)
77%
Closely correlated
+2.81%
BRKR
(undefined stocks)
77%
Closely correlated
+1.73%
analytics
(undefined stocks)
68%
Closely correlated
+4.91%
medical devices
(undefined stocks)
66%
Loosely correlated
+2.84%
medical service
(undefined stocks)
61%
Loosely correlated
+2.66%
More